Latent TB Detection Market to Grow at a CAGR of 5.2% to reach US$ 1,684.86 million from 2020 to 2027

report image

Latent TB Detection Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)); End User (Hospitals, Diagnostic Centers, Laboratories, and Others) and Geography

Publication Month: Apr 2021 | Report Code: TIPRE00014239 | No. of Pages: 137 | Category: Medical Device | Status: Published

The latent TB detection market is expected to reach US$ 1,684.86 million in 2027 from US$ 1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027.  

The growth of the market is attributed to the increasing prevalence of tuberculosis and government initiatives to promote tuberculosis detection. However, multidrug resistant tuberculosis (MDR-TB) is likely to hamper the growth of the Latent TB Detection market to a certain extent.

Lucrative Regional Markets for Latent TB Detection

Lucrative Regional Markets for Latent TB Detection

Get more information on this report :


Market Insights

Government Initiatives to Promote Tuberculosis Detection

The disease disproportionally affects the poor, vulnerable, undernourished, and marginalized people worldwide. Evidence from various sources such as World Health Organization (WHO) and the United Nations (UN) shows that countries such as India and Indonesia in Asia Pacific are highly populated with patients suffering from TB. Thus, the government bodies in these countries are undertaking and adopting certain schemes and initiatives in containing the disease. For instance, the Indian National Strategic Plan (NSP) that aims for TB elimination has been established from 2017 to 2025; it institutes several patient support groups and protection measures along with the provision of free TB diagnostic tests and treatment for Indians. Furthermore, in March 2018, the Government of India, in association with the Directorate of General Health Services, introduced a new scheme known as “Nikshay Poshak Yojna” that included the provision of nutritional support for patients suffering with TB in India. Similarly, another scheme known as Direct Benefit Transfer (DBT) has been introduced for patients suffering from TB. This policy involves direct transfer of cash to the victim’s account intended for TB diagnostic tests, treatments, and medication costs.

Furthermore, western countries such as the US, the UK, and Canada are giving significant importance in combating TB by undertaking various funding programs. The US government is the largest donor of the Global Fund to fight AIDS, tuberculosis, and malaria. The US funding for global TB efforts was reported to be US$ 321 million in 2020. Thus, the financial and medical assistance from the governments for fighting the disease and promoting the diagnosis of TB is providing a lucrative scenario for the growth of the market.

Test-Based Insights

Based on test, the latent TB detection market was segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). In 2019, the Interferon Gamma Released Assay (IGRA) segment accounted for the highest share in the market and is likely to retain its dominant share. Also, the similar segment is expected to witness fastest growth in the market owing to the accuracy obtained through these tests. The IGRA test has numerous advantages over the TST of not needing the patient to return for test result evaluation. Current IGRAs do not cross-react with most non-TB mycobacteria, including Bacille Calmette-Guerin (BCG) strains.

Latent TB Detection Market, by Test – 2019 and 2027

Latent TB Detection Market, by Test – 2019 and 2027

Get more information on this report :


End User-Based Insights

Based on end user, the latent TB detection market is segmented into hospitals, diagnostic centers, laboratory and others. The hospitals segment held the largest share of the market in 2019. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - Latent TB Detection Market
Report CoverageDetails
Market Size Value inUS$ 1,131.82 Million in 2019
Market Size Value byUS$ 1,684.86 Million by 2027
Growth rateCAGR of 5.2% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages137
No. of Tables51
No. of Charts & Figures64
Historical data availableYes
Segments coveredTest and Interferon Gamma Released Assay ); End User and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The latent TB detection market players such as QIAGEN, BioMeriux S.A., F. Hoffmann La-Roche Ltd., BD, ARKRAY, Inc., Abbott, Serum Institute of India Pvt. Ltd, Oxford Immunotec Ltd, Lionex GmbH have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in September 2020, Oxford Immunotec received approval from the FDA to allow use of the T-SPOT.TB test in two years of age and older. This will help in meeting the pediatric patients needs for TB management

Latent TB Detection Market– by Test

  • Tuberculin Skin Test (TST)
  • Interferon Gamma Released Assay (IGRA)

Latent TB Detection Market– by End User

  • Hospitals
  • Diagnostic Centers
  • Laboratories
  • Others

Latent TB Detection Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East &Africa
  • South and Central America

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • QIAGEN
  • BioMeriux S.A.
  • F. Hoffmann La-Roche Ltd.
  • BD
  • ARKRAY, Inc.
  • Abbott
  • Serum Institute of India Pvt. Ltd
  • Oxford Immunotec Ltd
  • Lionex GmbH

The List of Companies - Latent TB Detection Market

  1. QIAGEN
  2. BioMeriux S.A.
  3. F. Hoffmann La-Roche Ltd.
  4. BD
  5. ARKRAY, Inc.
  6. Abbott
  7. Serum Institute of India Pvt. Ltd
  8. Oxford Immunotec Ltd
  9. Lionex GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the latent TB detection market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global latent TB detection market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00014239
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount